KAISER PETER (Chief Development Officer) sold 3.8% of their position (9.99K shares) of OCULAR THERAPEUTIX, INC on the open market
Open‑market sale worth $70.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/6/2026ACC: 0001104659-26-114081
Officer· Chief Development Officer
Since Feb 2026
-9.99K
Net shares
Net seller
$70.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.99K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.99K
Price / share
$7.05
Trade value
$70.43K
% of position
3.8%
10/2/2026
264.38K→254.39K
Total
Net shares
−9.99K
Net value
-$70.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/2/2026 | S · Sale | −9.99K | $7.05 | $70.43K | 3.8% | 264.38K | 254.39K |
| Total | −9.99K | -$70.43K | ||||||
Derivative Transactions0
No derivative transactions reported